The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Novo Nordisk scored approval to sell its Wegovy weight loss drug in China. That’s a big win, but competitors will soon flood in.
As the frequency of cyberattacks on healthcare systems and hospitals increases, so too do the costs for preventing them.
Chipotle is the only food chain among the top 20 best-performing stocks on the S&P 500 this year. So what’s the secret to its success?
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
Big Tech loves movies, TV shows, and live sports. So why has it shown remarkably little appetite for the TV news business?
You’d think the biggest election year in history would be good news for pollsters. In the case of YouGov, you’d be wrong.
Tesla wants to make sure its autonomous vehicles don’t fall for light tricks.
De Beers, the world’s largest diamond producer, said it plans to shutter its lab-grown jewelry brand LightBox.
A patent from Honda seeks to make EV charging cheaper and better for the environment.
We check in on two planned smart cities in Saudi Arabia and Guyana to see if the future is any closer to arrival.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.